ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Caprolactam Chemicals internal auditor Shrey Pandey & Associates resigned effective 10 Sept 2026. Parth Patel D & Associates was appointed as the new internal auditor for FY 2026-27.
Caprolactam Chemicals Ltd. has issued a notice for its 37th Annual General Meeting to be held on September 28, 2026, through video conference.
Caprolactam Chemicals Ltd announced the recommendation of M/s. Raman S. Shah & Co as Statutory Auditor and approved the notice and scrutinizer for its 37th AGM.
Caprolactam Chemicals Ltd reported revenue from operations of ₹0.5 Cr (-80.8% YoY) and a net loss of ₹1 Cr for Q1 FY27.
Caprolactam Chemicals Limited has scheduled a board meeting on August 13, 2026. The board will consider unaudited standalone financial results for the quarter ended June 2026.
CAPROLACTAM Chemicals Ltd discloses its shareholding pattern for quarter ending 30 June 2026, detailing promoter, promoter group, and public holdings. The filing complies with Regulation 31(1)(b) requirements.
Caprolactam Chemicals Ltd reported revenue from operations of ₹3.1 Cr (+93.8% YoY) and net profit of ₹0.8 Cr for Q4 FY26.
Caprolactam Chemicals Ltd approved its audited FY2026 financial results, reporting annual total income of ₹10.59 Crore. The board also appointed M/s. Shrey Pandey & Associates as internal auditors.
Caprolactam Chemicals Ltd has scheduled a Board Meeting on May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window remains closed until 48 hours after the results announcement.
Caprolactam Chemicals Ltd informed BSE that compliance with SEBI Regulation 23(9) regarding Related Party Transaction disclosures is not applicable. The company cited a paid-up equity capital of ₹4.60 Crore and net worth of ₹4.96 Crore, both below the thresholds specified under Regulation 15(2) of SEBI (LODR) Regulations, 2015.
Caprolactam Chemicals Ltd submitted its initial disclosure under the SEBI Large Corporate framework for FY 2026. The company reported outstanding borrowings of ₹9.23 Crore as of the applicable period end. This is a regulatory filing confirming the company's status and compliance with debt market borrowing norms.
Caprolactam Chemicals Ltd submitted its quarterly confirmation certificate under Regulation 74(5) for the period ended March 31, 2026. The report, issued by Purva Sharegistry (India) Pvt. Ltd., confirms the processing and listing of dematerialised securities for various shareholders including Rajesh Bhagatlal Modi and Kirti Mohanlal Jain.
Caprolactam Chemicals Ltd reported net profit of ₹0.4 Cr for Q3 FY26.